IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GALLI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 31.512
NA - Nord America 25.956
AS - Asia 12.592
SA - Sud America 674
AF - Africa 282
OC - Oceania 250
Continente sconosciuto - Info sul continente non disponibili 45
Totale 71.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.893
GB - Regno Unito 12.273
IT - Italia 5.456
CN - Cina 4.804
DE - Germania 3.950
SE - Svezia 2.834
SG - Singapore 2.754
RU - Federazione Russa 1.723
TR - Turchia 1.107
IE - Irlanda 1.058
KR - Corea 985
IN - India 972
CA - Canada 952
FR - Francia 896
UA - Ucraina 867
FI - Finlandia 606
NL - Olanda 490
HK - Hong Kong 485
EU - Europa 418
BR - Brasile 320
BE - Belgio 290
ID - Indonesia 289
VN - Vietnam 249
AU - Australia 222
CO - Colombia 215
JP - Giappone 178
ES - Italia 147
PL - Polonia 146
CH - Svizzera 135
GR - Grecia 130
DK - Danimarca 122
TW - Taiwan 112
IR - Iran 101
RO - Romania 101
IL - Israele 76
TH - Thailandia 76
SA - Arabia Saudita 74
PH - Filippine 71
MX - Messico 64
PT - Portogallo 62
PK - Pakistan 55
MY - Malesia 47
ZA - Sudafrica 46
AR - Argentina 42
NO - Norvegia 42
KE - Kenya 35
CL - Cile 31
CZ - Repubblica Ceca 28
NZ - Nuova Zelanda 28
EG - Egitto 27
ET - Etiopia 26
PE - Perù 26
UZ - Uzbekistan 26
IQ - Iraq 24
TZ - Tanzania 23
AT - Austria 22
BG - Bulgaria 21
BD - Bangladesh 19
EC - Ecuador 19
SC - Seychelles 17
NG - Nigeria 15
OM - Oman 15
HR - Croazia 14
HU - Ungheria 14
A2 - ???statistics.table.value.countryCode.A2??? 13
LB - Libano 12
BY - Bielorussia 11
GH - Ghana 11
RS - Serbia 11
AE - Emirati Arabi Uniti 10
MK - Macedonia 10
KY - Cayman, isole 9
LT - Lituania 9
MA - Marocco 9
PA - Panama 9
UG - Uganda 9
CU - Cuba 8
DZ - Algeria 8
QA - Qatar 8
PY - Paraguay 7
SI - Slovenia 7
AL - Albania 6
BA - Bosnia-Erzegovina 6
BW - Botswana 6
KH - Cambogia 6
TN - Tunisia 6
AN - Antille olandesi 5
BO - Bolivia 5
CI - Costa d'Avorio 5
CM - Camerun 5
JO - Giordania 5
KW - Kuwait 5
KZ - Kazakistan 5
MW - Malawi 5
PR - Porto Rico 5
CR - Costa Rica 4
LK - Sri Lanka 4
MD - Moldavia 4
MT - Malta 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 71.621
Salva come PNG Salva come JPEG
Città #
Southend 11.232
Chandler 2.614
Fairfield 2.440
Singapore 1.879
Seattle 1.745
Cambridge 1.650
Milan 1.590
Frankfurt am Main 1.236
Wilmington 1.221
Princeton 1.213
Ashburn 1.170
Ann Arbor 1.160
Dublin 1.041
Woodbridge 1.034
Houston 1.033
Beijing 917
Toronto 579
Redmond 549
Boardman 514
Jacksonville 510
Dearborn 508
Nanjing 452
Des Moines 444
Santa Clara 377
Redwood City 361
Mountain View 355
Hong Kong 337
Bengaluru 327
Sakarya 309
Columbus 289
Hanover 283
Shanghai 234
Somerville 232
Brussels 224
Phoenix 221
Andover 217
Rome 204
Serra 202
Ottawa 197
Seoul 191
New York 177
Jinan 176
Shenyang 172
Helsinki 169
Berlin 166
Grafing 166
Jakarta 164
Bogotá 162
Guangzhou 153
Istanbul 145
Nanchang 129
San Diego 129
Dong Ket 104
Los Angeles 104
Changsha 103
Athens 100
London 99
Hebei 98
Warsaw 97
Turin 93
Fuzhou 92
Falls Church 91
Tianjin 85
Mumbai 84
Fremont 83
Zhengzhou 76
Central District 70
Kent 69
Bühl 67
São Paulo 67
Eitensheim 63
Taipei 63
Kiez 62
Hangzhou 61
Tokyo 61
Wuhan 61
Jiaxing 57
Nürnberg 55
Auburn Hills 54
Margão 53
Boise 51
Quanzhou 51
Silver Spring 50
Pisa 49
Hefei 47
Kunming 46
Paris 46
Sydney 44
Haikou 42
Roxbury 40
Sunnyvale 40
Chicago 39
Ningbo 39
Norwalk 39
Taizhou 39
Washington 39
Bitonto 38
Amsterdam 37
Bangkok 36
Hamburg 36
Totale 46.219
Salva come PNG Salva come JPEG
Nome #
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 4.098
Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study 966
Distribution of Marburg virus in Africa: An evolutionary approach 636
Significato clinico della variabilità virale : il virus dell'epatite B 595
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 541
Gastrointestinal basidiobolomycosis: an emerging mycosis difficult to diagnose but curable: Case report and review of the literature 530
Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population : results from the large Italian web-based EPICOVID19 cross-sectional survey. (Preprint) 446
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets 427
Prevalenza ed epidemiologia molecolare di HTLV-1 in immigrati HIV positivi e in soggetti viventi in Perù e in Africa Occidentale 371
Non-human primate and human malaria: past, present and future 346
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 326
Bayesian reconstruction of the evolutionary history and cross-species transition of variola virus and orthopoxviruses 324
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial 319
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study 316
Are health indicators able to describe the ability to cope of Health Systems with COVID-19 epidemic? 301
When food can make the difference : The case of elvitegravir-based co-formulation 293
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 285
Bayesian phylogeography of Crimean-Congo hemorrhagic fever virus in Europe 283
Description of a "Trans-Saharan" strain of human T-Lymphotropic virus type 1 in West Africa 276
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms 274
Severe Plasmodium falciparum malaria in the intensive care unit : A 6-year experience in Milano, Italy 271
Imported dengue fever: a 16-years retrospective analysis in Milan (Italy) and a brief review of the European literature 268
Profile of infective endocarditis observed from 2003 - 2010 in a single center in Italy 254
Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy 250
Rapid COVID-19 Screening Based on Self-Reported Symptoms:Psychometric Assessment and Validation of the EPICOVID19Short Diagnostic Scale 248
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 244
Prevalence of HIV-1 resistant strains in recent seroconverters 236
The Milano Sforza Registers 234
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin 232
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 232
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens 231
Prevalence and risk determinants of HIV-1 and HIV-2 infections in pregnant women in Bissau 231
Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-Positive patients lacking CD4+ gain on antiviral therapy 230
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts : Data from the Icona Foundation Cohort 230
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis 227
Gammaglutamyltranspeptidase (gamma-GT) levels before treatment are predictive of Tipranavir interruption in ART multiexperienced HIV-1-infected patients 226
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir 225
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 224
Italian consensus statement on management of HIV-infected individuals with advanced disease naive to antiretroviral therapy 223
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region : outcome after treatment in recently infected individuals 218
Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes 217
Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients : is it time to revise atazanavir dosages? 217
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings 215
Within-host dynamics of the hepatitis C virus quasispecies population in HIV-1/HCV coinfected patients 213
Reconstruction of the Evolutionary Dynamics of the A(H1N1)pdm09 Influenza Virus in Italy during the Pandemic and Post-Pandemic Phases 212
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection 211
Controversy concerning role of ultrasonographic lipoatrophy assessments in HIV patients 210
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation 208
Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy 204
Heterogeneity of covid-19 outbreak in italy 203
A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients 202
Comparability of echographic and tomographic assessments of body fat changes related to the HIV associated adipose redistribution syndrome (HARS) in antiretroviral treated patients 200
Chagas disease knocks on our door : A cross-sectional study among Latin American immigrants in Milan, Italy 200
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 200
Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy 199
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects 198
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection 197
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis 197
Prevalenza ed epidemiologia molecolare di HBV in soggetti HIV-1 positivi e in coppie mamma/bambino viventi in Perù 196
Epidemiological and clinical characteristics of imported malaria in adults in Milan, Italy, 2010-2015 196
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 194
Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results 192
Aspergillus meningitis : a rare clinical manifestation of central nervous system aspergillosis : case report and review of 92 cases 192
Vpr and HIV-1 disease progression : R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients 191
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics 191
In vitro efficacy of a non-conventional (folding) HIV-1 protease inhibitor without selection of resistance 190
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study 188
Performance of genotypic tropism testing on proviral DNA in clinical practice : results from the DIVA study group 187
Reliable timescale inference of HBV genotype A origin and phylodynamics 187
Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection 185
Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events 185
Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2 185
Are Epidemiological Estimates Able to Describe the Ability of Health Systems to Cope with COVID-19 Epidemic? 185
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression : 48-week efficacy and safety results 184
Susceptibility to a non-conventional (folding) protease inhibitor of human immunodeficiency virus type 1 isolates in vitro 183
Preliminary classification criteria for the cryoglobulinaemic vasculitis 182
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART 181
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1 180
Local epidemics gone viral : evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 179
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy 178
Atazanavir-induced severe episodes of kidney stones in an HIV-1-infected subject characterized by a CYP3A poor metabolizer phenotype 178
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals 177
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV : experience in a pediatric population 177
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades 177
Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography 176
Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol 175
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses 174
Favorable therapeutic response with an antiretroviral salvage regimen in an HIV-1-positive subject infected with a CRF11-cpx virus 174
IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients 172
Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy 171
Effect of Antioxidants on Mitochondrial Function in HIV-1-Related Lipoatrophy : A Pilot Study 171
Durability of INI-containing regimens after switching from PI-containing regimens : a single-centre cohort of drug-experienced HIV-infected subjects 171
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates 169
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 169
Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS : a retrospective study of 1,630 autopsies performed between 1984 and 2002 167
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: Results of a 3-year cohort study 167
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection : in vitro studies of mixed virus infections 166
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation 166
Genomic characterisation and phylogenetic analysis of SARS-COV-2 in Italy 166
An update on integrase inhibitors : new opportunities for a personalized therapy? The NEXTaim Project 165
Totale 27.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 201.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.192 0 0 0 0 501 803 869 456 953 935 352 323
2020/202110.826 520 571 664 658 1.060 857 675 748 1.441 952 1.785 895
2021/202211.982 1.519 802 933 996 685 735 1.049 801 1.185 878 869 1.530
2022/202310.351 1.198 1.062 866 1.215 1.023 1.894 303 615 1.146 191 517 321
2023/20247.144 290 525 379 365 1.431 601 508 539 277 488 728 1.013
2024/20255.343 697 1.579 474 1.683 910 0 0 0 0 0 0 0
Totale 75.374